Deeni Taylor del Mar - 01 Mar 2024 Form 4 Insider Report for Physicians Realty Trust

Role
EVP-Chief Investment Officer
Signature
/s/ Christopher M. Bartoli, as attorney-in-fact
Issuer symbol
N/A
Transactions as of
01 Mar 2024
Net transactions value
-$1,270,719
Form type
4
Filing time
01 Mar 2024, 16:12:47 UTC
Previous filing
22 Jan 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DOC Common shares, $0.01 par value Options Exercise +116,115 +58% 314,689 01 Mar 2024 Direct F1
transaction DOC Common shares, $0.01 par value Options Exercise +135,675 +43% 450,364 01 Mar 2024 Direct F2
transaction DOC Common shares, $0.01 par value Tax liability $1,270,719 -113,154 -25% $11.23 337,210 01 Mar 2024 Direct
transaction DOC Common shares, $0.01 par value Disposed to Issuer -337,210 -100% 0 01 Mar 2024 Direct F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction DOC 2022 Performance Based Restricted Share Unit Grant Options Exercise $0 -38,705 -100% $0.000000* 0 01 Mar 2024 Common shares, $0.01 par value 38,705 Direct F4
transaction DOC 2023 Performance Based Restricted Share Unit Grant Options Exercise $0 -45,225 -100% $0.000000* 0 01 Mar 2024 Common shares, $0.01 par value 45,225 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Deeni Taylor del Mar is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id Content
F1 Represents vesting of the 2022 Performance Based Restricted Share Units granted on March 1, 2022 under the Issuer's Equity Incentive Plan (the "Plan"). The grant vested on March 1, 2024 pursuant to the terms of the Agreement and Plan of Merger (the "Merger Agreement") dated October 29, 2023 among the Issuer, Physicians Realty L.P., Healthpeak Properties, Inc. ("Healthpeak"), DOC DR Holdco, LLC and DOC DR LLC. The Company merged with and into DOC DR Holdco, LLC on March 1, 2024. Pursuant to the terms of the Merger Agreement, the Reporting Person received 116,115 common shares upon vesting, 300% of the target shares.
F2 Represents vesting of the 2023 Performance Based Restricted Share Units granted on March 1, 2023 under the the Plan. Pursuant to the terms of the Merger Agreement, the Reporting Person received 135,675 common shares upon vesting, 300% of the target shares.
F3 Represents securities disposed of pursuant to the terms of the the Merger Agreement and each issued and outstanding common shares of the Issuer, held by the reporting person was automatically converted into the right to receive 0.674 of a share of Healthpeak common stock, subject to any adjustment, without interest.
F4 On March 1, 2022, the Reporting Person was granted 38,705 performance share units under the Issuer's Plan, which represent the "target" number of shares underlying the performance share units. Pursuant to the terms of the merger, the Reporting Person received 116,115 common shares upon vesting.
F5 On March 1, 2023, the Reporting Person was granted 45,225 performance share units under the Issuer's Plan, which represent the "target" number of shares underlying the performance share units. Pursuant to the terms of the merger, the Reporting Person received 135,675 common shares upon vesting.